Stage IV Melanoma


Investigational Melanoma Drug Shrinks Tumors in Phase III Trial (07-2-2013)

In a Phase III clinical trial, the investigational drug T-VEC (talimogene laherparepvec) produced durable responses in people with advanced melanoma.  These results were presented at the 2013 Annual Meeting of the American Society of Clinical Oncology... Continue Reading

Anti-PD-1 Drugs Promising for Advanced Melanoma (07-1-2013)

In Phase I clinical trials, investigational drugs that target a protein known as PD-1 are showing promise for the treatment of advanced melanoma. Results from two of the trials were presented at the 2013 Annual Meeting of the American Society of Clinical... Continue Reading

Selumetinib Active Against Melanoma of the Eye (06-26-2013)

In a Phase II clinical trial, the investigational targeted drug selumetinib resulted in tumor shrinkage in half of patients with advanced melanoma of the eye. These results were presented at the 2013 Annual Meeting of the American Society of Clinical... Continue Reading